info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
Home » Healthcare » Blood Glucose Test Strip Market Size, Global Report Analysis, 2030

Blood Glucose Test Strips Market By Technology (Glucose Dehydrogenase (GDH), Glucose Oxidase (GOD)), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Pre-Diabetes), By End-user (Individuals, Hospitals & Clinics, Others), By Geography, Size, Global Report Analysis, Industry Forecast, 2021-2030

Published On: May-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 16232065

Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Test Conducted & Demand by Technology, Application & End-User
 

The global blood glucose test strips market size was $12.31 billion in 2021 and is poised to grow at a CAGR of 6.2% to reach $21.16 billion by 2030 during the forecast period 2021 - 2030. Because of the provision of healthcare reimbursements and the rapid adoption of new medical technology, North America comprised the highest market share of around 55 % in 2020.

Blood glucose test strips are a crucial component of the blood glucose testing process. These small disposable plastic strips may appear minor, yet they play a critical function in assisting people with diabetes and in monitoring and controlling their condition. In the majority of cases, each meter will only accept one type of test strip. However, certain blood glucose meters can also test ketone levels using blood ketone strips.

Blood Glucose Test Strips Market Infographics

Blood combines with a component called glucose oxidase on the test strip, developing gluconic acid from the glucose present in the blood. An electric pulse is transferred to the test strip by the meter at the other end of the test strip. Electric terminals on the strip allow the meter to calculate the current flowing between them, which varies based on the gluconic acid generated. Based on the difference in current, the blood glucose meter employs an algorithm to calculate the blood glucose level. According to a T1International poll, more than 38% of people with diabetes in the United States and 33% worldwide have subsidized blood glucose testing supplies. Some test strips, which aren't as often used these days, don't require the use of a meter. When blood is applied to the active area of the strip and then wiped away after a predetermined amount of time, the reagent changes colour, and the result can be determined by comparing the colour to a colour chart on the pot's side. Although it is less precise than a blood glucose meter, test strips are also less expensive. The emergence of innovative marketing methods and an increase in the number of diabetic patients are driving the industry.

Market Dynamics: 

Market Drivers: - (Increase in the diabetic population, technological advancements, and government support)

  • The percentage of diabetic patients around the globe is steadily increasing. According to the International Diabetic Federation, Diabetes affects around 537 million adults, with the overall number of diabetics expected to climb to 643 million by 2030 and 783 million by 2045. The growing diabetes population is propelling the blood glucose test strip industry forward. Diabetes Research Institute Foundation says that type 1 diabetes affects around 1.6 million people and accounts for approximately 5.2 % of all diagnosed cases of diabetes.

 

  • Diabetes is a major source of concern for governments worldwide because it influences the demand for visual blood glucose strips and government financial assistance (blood glucose meter readings by FDA), which are the significant economic drivers of the industry. The International Diabetic Federation reported that diabetes resulted in at least USD 966 billion in health expenditure, accounting for 9% of total adult spending. Moreover, The Government of Canada has proposed new diabetes research investments through the Canadian Institutes of Health Research (CIHR), which will recommit to the JDRF-CIHR partnership to fight diabetes, investing up to $15 million, which will be matched by JDRF Canada and its donors for a total research impact of $30 million.

 

Market Restraints: - (Paucity of knowledge, error in strips, and unfavourable reimbursement costs)

  • The blood glucose test strips market is likely to be hampered by a lack of knowledge about preventative care, particularly in developing countries, errors in self-monitoring strips, and an absence of reimbursement policies for test strips.

 

Opportunities: - (Rising awareness, Improved R&D, and higher adaptation)

  • Increasing awareness and a higher adaptation rate of continuous glucose monitors will help the market flourish in the future. The significant sales growth rates of major continuous glucose monitors (CGM) manufacturers indicate that global CGM use is still gaining traction. Abbott Diabetes Care witnessed a robust 33.0% increase in sales, led by their CGM, FreeStyle Libre, which generated nearly $1 billion in sales in the third quarter (Q3) of 2021, mostly due to new customer growth. The device added over 200,000 new users during the quarter, bringing Libre's total global user base to over 3.5 million. Dexcom, Abbott's main CGM competitor, reported revenue of $650.2 million, up 30% year over year, with organic growth of 46% outside the US attributable to new clients.

 

  • The market gazes an opportunity as disposable income rise, R&D activities are prioritized, and the purchasing habits of the emerging nations improve. GlucoWise is a sensor that can monitor blood glucose levels by simply inserting it between the thumb and forefinger on the skin. MediWise, the UK based company behind the technology, was acquired by Metamaterial Technologies, a Canadian company specializing in smart materials and photonics. In July 2021, Metamaterial Technologies launched human trials of a version of GlucoWise that combines a range of wavelength sensors and machine learning to produce more accurate findings.

blood glucose test strips market by share 2020-2030

The Global Blood Glucose Test Strips Market Analysis Of Different Segmentations:

The industry segmentation analysis is based on Technology, Application, End Users, and Region.

Based on Technology

  • Glucose Dehydrogenase (GDH)

  • Glucose Oxidase (GOD)

 

Based on Application

  • Type 1 Diabetes

  • Type 2 Diabetes

  • Gestational Diabetes

  • Pre-Diabetes

 

Based on End-user

  • Individuals

  • Hospitals & Clinics

  • Others

 

Based on Region:

  • North America

  • The United States

  • Canada

  • Rest of North America

 

Europe

  • France

  • Germany

  • Italy

  • Spain

  • the United Kingdom

  • Russia

  • Rest of Europe

 

Latin America

  • Mexico

  • Brazil

  • Rest of Latin America

 

Asia-Pacific

  • Japan

  • South Korea

  • China

  • India

  • Australia

  • Vietnam

  • Malaysia

  • Indonesia

  • Thailand

  • Rest of Asia-Pacific

 

MEA

  • Saudi Arabia

  • Iran

  • Egypt

  • Oman

  • South Africa

  • Rest of MEA

 

Based on Technology, 70 % of the market consists of glucose dehydrogenase (GDH) test strips. Self-monitoring blood glucose (SMBG) devices have increased as accuracy in measuring blood glucose levels has improved, particularly in critical care settings. In addition, GDH testing strips are devoid of oxygen, galactose, and maltose interfaces, allowing them to measure sugar levels in human blood correctly. As a result, the self-monitoring blood glucose strips market is growing exponentially. 

 

Based on the Application, the Type 2 Diabetes category is expected to gain a significant blood glucose test strips market share during the anticipated period. Because of their sedentary lifestyles, blood glucose levels in Type-2 diabetes patients are out of control, thus requiring them to monitor their blood sugar levels to avoid further issues. Type 2 diabetes accounts for 90 to 95 % of all diagnosed cases of diabetes in adults, as reported by the Centers for Disease Control and Prevention (CDC). Furthermore, gestational diabetes may impact 4.6 to 9.2 % of pregnancies. In close to 10% of cases, the women are diagnosed with type 2 diabetes shortly after birth, and in the coming 10 to 20 years, the rest of these women had a 35 to 60% probability of getting type 2 diabetes. As a result of the cause mentioned above, the demand for blood glucose test strips has grown widely across the globe.

 

Based on End User, by 2026, the hospitals and clinics industry will ship over 6 billion units of test strips, with a CAGR of around 8%. In addition, hospitals and clinics purchase test strips in bulk through buying groups. These have been the most commonly utilized devices in hospitals and ambulatory scenarios for detecting hyperglycemia, hypoglycemia, and glycemic variabilities since the advent of the COVID-19 pandemic. According to the CDC, in 2020, there were 7.8 million hospital discharges with diabetes as the primary diagnosis, and a severe cardiovascular condition was reported in 1.7 million of these discharges, including 438,000 ischemic heart disease and 313,000 strokes.

 

Based on Region, because of the provision of healthcare reimbursements and the rapid adoption of new medical technology, North America accounted for the highest share of 55 % in 2020. According to the Centers for Disease Control and Prevention (CDC), more than 29 million diabetic patients are currently present in North America, which is predicted to rise to 33 million by 2026. In 2020, the United States alone had approximately 25 million diabetic people, and nearly 90% of the people in this group have Type 2 diabetes. An estimated 37 % of the population in the United States aged 18 and above with diabetes also had chronic renal disease. Therefore, the need for test strips is expected to rise in tandem with the rising number of diabetes patients in this territory in the future years. 

 

Europe dominated the market in terms of volume, while APAC (Asia-Pacific) is predicted to be the fastest-growing industry at a CAGR of over 14%.

 

Report Attribute

Details

Forecast Period

2021 - 2030

Market size value in 2021

USD 12.31 billion

Revenue forecast in 2030

USD 21.16 billion

Growth rate

CAGR of 6.2 %

The base year for estimation

2021

Historical data

2015 – 2019

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Technology, By Application, By End User, By Region

By Technology

Glucose Dehydrogenase, Glucose Oxidase

By Application

Pre-Diabetes, Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes

By End-User

Individuals, Hospitals & Clinics, Others

By Region

North America, Middle East & Africa, Asia Pacific, Europe, and Latin America

Country Scope

US, Mexico, Canada, Germany, UK, France, China, Japan, India etc.

Company Usability Profiles

Lifescan, Bayer, Abbott, ARKRAY, I-SENS, Omron, B. Braun, 77 Elektronika, Nipro Dagnostics

 

Global Blood Glucose Test Strips Market A 360-Degree Analysis Of Competitive Landscape 

The competitive landscape analysis gives an overview of some prominent players operating in the market. Product innovation and continued R&D operations to create sophisticated technologies have assisted the industry growth. 

 

In the target industry, there are many significant companies, such as:

  • Roche

  • Lifescan

  • Bayer

  • Abbott

  • ARKRAY

  • I-SENS

  • Omron

  • B. Braun

  • 77 Elektronika

  • Nipro Dagnostics

  • AgaMatrix

  • Infopia

  • All Medicus

  • Terumo Corporation

  • Hainice Medical

blood glucose test strips market by region 2020-2030

 

Recent Developments:

  • On January 2022, Roche Diagnostics USA established a strategic agreement with Glytec, a cloud-based insulin management software supplier across the continuum of care. To address the issues of inpatient blood sugar management at the hospital bedside, this digital health collaboration incorporates Roche's expertise in medical devices and IT solutions with Glytec's FDA-cleared insulin dosing decision support software, Glucommander. Glucommander will be the first software programme available for Roche's Cobas pulse smart-device next-generation hospital blood glucose system, which is aimed to improve patient safety and care by allowing point-of-care doctors to collect and act on glycaemic management data in real-time.

 

  • On July 2021, the Australian experts declared that the "holy grail" of blood sugar monitoring for diabetics is a non-invasive strip that detects glucose levels via saliva. According to Paul Dastoor, Professor of Physics at the University of Newcastle in Australia, who headed the team that developed it, the latest test works by embedding an enzyme that accurately detects glucose inside a transistor.

 

  • On February 2021, Roche introduced the Accu-Chek Instant system, a new "connected" blood glucose monitoring (BGM) solution that complements and facilitates Roche's integrated Personalized Diabetes Management strategy (iPDM). iPDM is a patient-centred, holistic therapy strategy with the ultimate objective of personalizing diabetes treatment to enhance clinical outcomes and simplify care. iPDM aids in the improvement of the treatment process by enabling interaction between patients and the medical team and incorporating data visualization and analysis capabilities.

 

  • On January 2020, Roche Diabetes Care (RDC) India announced the launch of their new Accu-Chek Guide blood glucose monitoring device, which has novel features and an easy-to-use design. The new Accu-Chek Guide is simple, with an intuitive interface and a better testing experience. Moreover, the meter's accuracy level surpasses the system's accuracy criteria for blood glucose monitoring systems. 

 

Various devices that the market leaders are manufacturing are:

 

Name of the Product

Function

Key Player

Verio Reflect meter

It aids in identifying whether the blood sugar levels are high or low so that certain measures may be taken before they go out of range.

LifeScan IP Holdings

 

Safe-T-Pro Uno

It helps in obtaining small blood samples

Roche

 

FreeStyle Libre

A reader and a sensor are included in this sensor-based glucose monitoring device which is worn on the upper arm and can last up to 14 days.

Abbott

Frequently Asked Question About This Report

The global blood glucose test strips market is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2030 to reach USD 21.16 billion by 2030.

The global blood glucose test strips market size was $12.31 billion in 2021 and is poised to grow at a CAGR of 6.2% to reach $21.16 billion by 2030.

Some of the global players are Roche, Lifescan, Bayer, Abbott, ARKRAY, I-SENS, Omron B. Braun, 77 Elektronika, Nipro Diagnostics, AgaMatrix, etc.

The price for 50 strips starts from USD 6.5, and it can increase based on the company and quantity of strips.

Strips coated with glucose oxidase can be used for glucose testing.

North America accounted for the highest share of approximately 55 % in 2020.

The emergence of innovative marketing methods and an increase in the number of diabetes patients are driving the industry.

Source   https://idf.org/

              https://www.t1international.com/

              https://www.cdc.gov/

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1  Blood Glucose Test Strips Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1  Market Snapshot

       4.2  Global Blood Glucose Test Strips Market

              4.2.1      Global market, 2021-2030 (USD Million)

       4.3  Regional Analysis

              4.3.1      Global market, by region, 2021-2030 (USD Million)

       4.4  By Technology Analysis

              4.4.1      Global market, By Technology, 2021-2030 (USD Million)

       4.5  By End-User Analysis

              4.5.1      Global market, By End-User, 2021-2030 (USD Million)

       4.6  Application Analysis

              4.6.1      Global market, By Application, 2021-2030 (USD Million)

  4.7       Value Chain Analysis

       4.8  Market Variable Analysis

              4.8.1      Market Drivers Analysis

              4.8.2      Market Restraints Analysis

       4.9Business Environment Analysis Tool

              4.9.1      Compression Therapy market PEST analysis

              4.9.2      Compression Therapy market Porter’s analysis

       4.10Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Application Analysis

              5.11.1.   Trends in Application (2014-2020)

              5.11.2.   Trends in Application (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturers Blood Glucose Test Strips Manufacturing Sites, Area Served, Product Technology

       6.3. Global Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Market: By Technology Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Glucose Dehydrogenase (GDH)

              7.3.1. Glucose Dehydrogenase (GDH) market, 2021-2030 (USD Million)

       7.4. Glucose Oxidase (GOD)

              7.4.1. Glucose Oxidase (GOD) market, 2021-2030 (USD Million)

8. Global Market: By End-User Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Individuals

              8.3.1.     Individuals market, 2021-2030 (USD Million)

       8.4. Hospitals & Clinics

              8.4.1.     Hospitals & Clinics market, 2021-2030 (USD Million)

       8.5. Others

              8.5.1.     Others market, 2021-2030 (USD Million)

9. Global Market: By Application Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Type 1 Diabetes

              9.3.1.     Type 1 Diabetes market, 2021-2030 (USD Million)

       9.4. Type 2 Diabetes

              9.4.1.     Type 2 Diabetes market, 2021-2030 (USD Million)

       9.5. Gestational Diabetes

              9.5.1.     Gestational Diabetes market, 2021-2030 (USD Million)

       9.6. Pre-Diabetes

              9.6.1.     Pre-Diabetes market, 2021-2030 (USD Million)

10. Global Market: Regional Outlook

       10.1 North America

              10.1.1.   North America  market, by By Technology, 2021-2030 (USD Million)

              10.1.2.   North America  market, by By End-User, 2021-2030 (USD Million)

              10.1.3.   North America  market, by Application, 2021-2030 (USD Million)

              10.1.4.   North America  market, by Country, 2021-2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S. market, by By Technology, 2021-2030 (USD Million)

                     10.1.4.1.2.   U.S. market, by By End-User, 2021-2030 (USD Million)

                     10.1.4.1.3.   U.S. market, by Application, 2021-2030 (USD Million)

     10.1.4.2.  Canada

                     10.1.4.2.1.   Canada market, by By Technology, 2021-2030 (USD Million)

                     10.1.4.2.2.   Canada market, by By End-User, 2021-2030 (USD Million)

                     10.1.4.2.3.   Canada market, by Application, 2021-2030 (USD Million)

10.2. Europe

              10.2.1.   Europe market, by By Technology, 2021-2030 (USD Million)

              10.2.2.   Europe market, by By End-User, 2021-2030 (USD Million)

              10.2.3.   Europe market, by Application, 2021-2030 (USD Million)

              10.2.4.   Europe market, by country, 2021-2030 (USD Million)

    10.2.4.1    U.K.

                     10.2.4.1.1.   U.K. market, by By Technology, 2021-2030 (USD Million)

                     10.2.4.1.2.   U.K. market, by By End-User, 2021-2030 (USD Million)

                     10.2.4.1.3.   U.K. market, by Application, 2021-2030 (USD Million)

   10.2.4.2.           Germany

                     10.2.4.2.1.   Germany market, by By Technology, 2021-2030 (USD Million)

                     10.2.4.2.2.   Germany market, by By End-User, 2021-2030 (USD Million)

                     10.2.4.2.3.   Germany market, by Application, 2021-2030 (USD Million)

   10.2.4.3.           France

                     10.2.4.3.1.   France market, by By Technology, 2021-2030 (USD Million)

                     10.2.4.3.2.   France market, by By End-User, 2021-2030 (USD Million)

                     10.2.4.3.3.   France market, by Application, 2021-2030 (USD Million)

    10.2.4.4.          Rest of Europe

                     10.2.4.4.1.   Rest of Europe market, by By Technology, 2021-2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe market, by By End-User, 2021-2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe market, by Application, 2021-2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific market, by By Technology, 2021-2030 (USD Million)

              10.3.2.   Asia Pacific market, by By End-User, 2021-2030 (USD Million)

              10.3.3.   Asia Pacific market, by Application, 2021-2030 (USD Million)

              10.3.4.   Asia Pacific market, by country, 2021-2030 (USD Million)

   10.3.4.1.           China

                     10.3.4.1.1.   China market, by By Technology, 2021-2030 (USD Million)

                     10.3.4.1.2.   China market, by By End-User, 2021-2030 (USD Million)

                     10.3.4.1.3.   China market, by Application, 2021-2030 (USD Million)

   10.3.4.2.           India

                     10.3.4.2.1.   India market, by By Technology, 2021-2030 (USD Million)

                     10.3.4.2.2.   India market, by By End-User, 2021-2030 (USD Million)

                     10.3.4.2.3.   India  market, by Application, 2021-2030 (USD Million)

   10.3.4.3.           Japan

                     10.3.4.3.1.   Japan market, by By Technology, 2021-2030 (USD Million)

                     10.3.4.3.2.   Japan market, by By End-User, 2021-2030 (USD Million)

                     10.3.4.3.3.   Japan market, by Application, 2021-2030 (USD Million)

   10.3.4.4.           South Korea

                     10.3.4.4.1.   South Korea market, by By Technology, 2021-2030 (USD Million)

                     10.3.4.4.2.   South Korea market, by By End-User, 2021-2030 (USD Million)

                     10.3.4.4.3.   South Korea market, by Application, 2021-2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC market, by By Technology, 2021-2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America market, by By Technology, 2021-2030 (USD Million)

              10.4.2.   Latin America market, by By End-User, 2021-2030 (USD Million)

              10.4.3.   Latin America market, by Application, 2021-2030 (USD Million)

              10.4.4.   Latin America market, by country, 2021-2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil market, by By Technology, 2021-2030 (USD Million)

                     10.4.4.1.2.   Brazil market, by By End-User, 2021-2030 (USD Million)

                     10.4.4.1.3.   Brazil market, by Application, 2021-2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico market, by By Technology, 2021-2030 (USD Million)

                     10.4.4.2.2.   Mexico market, by By End-User, 2021-2030 (USD Million)

                     10.4.4.2.3.   Mexico market, by Application, 2021-2030 (USD Million)

                     10.4.4.3.       Rest of Latin America

                     10.4.4.3.1.   Rest of the Latin America market, by By Technology, 2021-2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America market, by By End-User, 2021-2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America market, by Application, 2021-2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA market, by By Technology, 2021-2030 (USD Million)

              10.5.2.   MEA market, by By End-User, 2021-2030 (USD Million)

              10.5.3.   MEA market, by Application, 2021-2030 (USD Million)

              10.5.4.   MEA market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

       11.1 Roche

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   Product Portfolio Analysis

              11.1.4.   Business Strategy & Recent Development

       11.2. Lifescan

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Business Strategy & Recent Development

       11.3. Bayer

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Business Strategy & Recent Development

       11.4. Abbott

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Business Strategy & Recent Development

       11.5. ARKRAY

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Business Strategy & Recent Development

       11.6. I-SENS

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Business Strategy & Recent Development

       11.7. Omron

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Business Strategy & Recent Development

       11.8. B. Braun

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Business Strategy & Recent Development

       11.9. 77 Elektronika

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Business Strategy & Recent Development

       11.10. Nipro Dagnostics

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Business Strategy & Recent Development

       11.11. AgaMatrix

              11.11.1. Company overview

              11.11.2. Financial performance

              11.11.3. Product Portfolio Analysis

              11.11.4. Business Strategy & Recent Development

       11.12. Infopia

              11.12.1. Company overview

              11.12.2. Financial performance

              11.12.3. Product Portfolio Analysis

              11.12.4. Business Strategy & Recent Development

       11.13. All Medicus

              11.13.1. Company overview

              11.13.2. Financial performance

              11.13.3. Product Portfolio Analysis

              11.13.4. Business Strategy & Recent Development

       11.14. Terumo Corporation

              11.14.1. Company overview

              11.14.2. Financial performance

              11.14.3. Product Portfolio Analysis

              11.14.4. Business Strategy & Recent Development

       11.15. Hainice Medical

              11.15.1. Company overview

              11.15.2. Financial performance

              11.15.3. Product Portfolio Analysis

              11.15.4. Business Strategy & Recent Development

 

List of Tables (59 Tables)

TABLE 1.  MARKET, By Technology, 2021-2030 (USD Million)

TABLE 2.  MARKET FOR Glucose Dehydrogenase (GDH), BY REGION, 2021-2030 (USD Million)

TABLE 3.  MARKET FOR Glucose Oxidase (GOD), BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET, By End-User, 2021-2030 (USD Million)

TABLE 5. MARKET FOR Individuals, BY REGION, 2021-2030 (USD Million)

TABLE 6. MARKET FOR Hospitals & Clinics, BY REGION, 2021-2030 (USD Million)

TABLE 7. MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 8. MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 9. MARKET FOR Type 1 Diabetes, BY REGION, 2021-2030 (USD Million)

TABLE 10. MARKET FOR Type 2 Diabetes, BY REGION, 2021-2030 (USD Million)

TABLE 11. MARKET FOR Gestational Diabetes, BY REGION, 2021-2030 (USD Million)

TABLE 12. MARKET FOR Pre-Diabetes, BY REGION, 2021-2030 (USD Million)

TABLE 13. MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 14. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 15. NORTH AMERICA MARKET, By Technology, 2021-2030 (USD Million)

TABLE 16. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million)

TABLE 17. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 18. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 19. EUROPE MARKET, By Technology, 2021-2030 (USD Million)

TABLE 20. EUROPE MARKET, By End-User, 2021-2030 (USD Million)

TABLE 21. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 22. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 23. ASIA-PACIFIC MARKET, By Technology, 2021-2030 (USD Million)

TABLE 24. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million)

TABLE 25. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 26. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 27. LAMEA MARKET, By Technology, 2021-2030 (USD Million)

TABLE 28. LAMEA MARKET, By End-User, 2021-2030 (USD Million)

TABLE 29. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 30. Roche: COMPANY SNAPSHOT

TABLE 31. Roche: OPERATING SEGMENTS

TABLE 32. Lifescan: COMPANY SNAPSHOT

TABLE 33. Lifescan: OPERATING SEGMENTS

TABLE 34. Bayer: COMPANY SNAPSHOT

TABLE 35. Bayer: OPERATING SEGMENTS

TABLE 36. Abbott: COMPANY SNAPSHOT

TABLE 37. Abbott: OPERATING SEGMENTS

TABLE 38. ARKRAY: COMPANY SNAPSHOT

TABLE 39. ARKRAY: OPERATING SEGMENTS

TABLE 40. I-SENS: COMPANY SNAPSHOT

TABLE 41. I-SENS: OPERATING SEGMENTS

TABLE 42. Omron: COMPANY SNAPSHOT

TABLE 43. Omron: OPERATING SEGMENTS

TABLE 44. B. Braun: COMPANY SNAPSHOT

TABLE 45. B. Braun: OPERATING SEGMENTS

TABLE 46. 77 Elektronika: COMPANY SNAPSHOT

TABLE 47. 77 Elektronika: OPERATING SEGMENTS

TABLE 48. Nipro Dagnostics: COMPANY SNAPSHOT

TABLE 49. Nipro Dagnostics: OPERATING SEGMENTS

TABLE 50. AgaMatrix: COMPANY SNAPSHOT

TABLE 51. AgaMatrix: OPERATING SEGMENTS

TABLE 52. Infopia: COMPANY SNAPSHOT

TABLE 53. Infopia: OPERATING SEGMENTS

TABLE 54. All Medicus: COMPANY SNAPSHOT

TABLE 55. All Medicus: OPERATING SEGMENTS

TABLE 56. Terumo Corporation: COMPANY SNAPSHOT

TABLE 57. Terumo Corporation: OPERATING SEGMENTS

TABLE 58. Hainice Medical: COMPANY SNAPSHOT

TABLE 59. Hainice Medical: OPERATING SEGMENTS

 

List of Figures (22 Figures)

Figure 1 Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Product-Based Estimation

Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Blood Glucose Test Strips, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Blood Glucose Test Strips, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million)

Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million)

Figure 13 Market Share, By Technology, 2019 vs. 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Glucose Dehydrogenase (GDH) to Witness Higher CAGR in Market for Technology Segment during Forecast Period.

Figure 16 Type 2 Diabetes to Witness Higher CAGR in Market for Application Segment during Forecast Period.

Figure 17 Hospitals & Clinics to Witness Higher CAGR in Market for End-User Segment during Forecast Period.

Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America Snapshot

Figure 21 Asia Pacific Snapshot

Figure 22 Vendor Dive: Evaluation Overview